Sponsor:
Icahn School of Medicine at Mount Sinai
Code:
NCT07786012
Conditions
Cesarean Delivery
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
buprenorphine
morphine
Brief summary:
Conditions
Cesarean Delivery
Study ID
NCT07786012
Start date
Oct 7, 2026
Status verified date
Oct, 2026
Completion date
Aug, 2028
Anticipated
Primary completion date
Aug, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Enrollment
180 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Buprenorphine
active comparator: Morphine
Interventions
buprenorphine
morphine
Primary outcome measure
Central contacts
Locations
Mount Sinai Hospital
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Daniel Katz
Sponsor
Icahn School of Medicine at Mount Sinai
Last update posted
Oct 16, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-17. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-10-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.